A mixed approach for proving non-inferiority in clinical trials with binary endpoints

被引:21
|
作者
Rousson, Valentin [1 ]
Seifert, Burkhardt [2 ]
机构
[1] Univ Lausanne, Inst Social & Prevent Med, Stat Unit, CH-1005 Lausanne, Switzerland
[2] Univ Zurich, Inst Social & Prevent Med, Biostat Unit, CH-8001 Zurich, Switzerland
关键词
active control; non-inferiofity margin; odds-ratio; difference of proportions; sample size calculation; test for non-inferiority;
D O I
10.1002/bimj.200710410
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
When a new treatment is compared to an established one in a randomized clinical trial, it is standard practice to statistically test for non-inferiority rather than for superiority. When the endpoint is binary, one usually compares two treatments using either an odds-ratio or a difference of proportions. In this paper, we propose a mixed approach which uses both concepts. One first defines the non-inferiority margin using an odds-ratio and one ultimately proves non-inferiority statistically using a difference of proportions. The mixed approach is shown to be more powerful than the conventional odds-ratio approach when the efficacy of the established treatment is known (with good precision) and high (e.g. with more than 56% of success). The gain of power achieved may lead in turn to a substantial reduction in the sample size needed to prove non-inferiority. The mixed approach can be generalized to ordinal endpoints.
引用
收藏
页码:190 / 204
页数:15
相关论文
共 50 条
  • [41] Non-inferiority trials in surgical oncology
    Fueglistaler, Philipp
    Adamina, Michel
    Guller, Ulrich
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (05) : 1532 - 1539
  • [42] Understanding non-inferiority trials: an introduction
    Brasher, Penelope M. A.
    Dobson, Gary
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2014, 61 (05): : 389 - 392
  • [43] The ethics of non-inferiority trials - Reply
    Garattini, Silvio
    Bertele', Vittorio
    LANCET, 2008, 371 (9616): : 896 - 897
  • [44] The limitations of equivalence and non-inferiority trials
    Rief, Winfried
    Hofmann, Stefan G.
    PSYCHOLOGICAL MEDICINE, 2019, 49 (02) : 349 - 350
  • [45] Non-Inferiority Trials in Surgical Oncology
    Philipp Fueglistaler
    Michel Adamina
    Ulrich Guller
    Annals of Surgical Oncology, 2007, 14 : 1532 - 1539
  • [46] Futility stopping in non-inferiority trials
    Su, Zheng
    Stuntz, Mark
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2019, 13
  • [47] Anger over non-inferiority trials
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (10) : 808 - 809
  • [48] Is there a danger of “biocreep” with non-inferiority trials?
    Primrose Beryl
    Werner Vach
    Trials, 12 (Suppl 1)
  • [49] Statistical Question: Non-inferiority trials
    Sedgwick, Philip
    BRITISH MEDICAL JOURNAL, 2011, 342
  • [50] Research Note: Non-inferiority trials
    Hinman, Rana S.
    Kasza, Jessica
    JOURNAL OF PHYSIOTHERAPY, 2023, 69 (02) : 129 - 132